Back to top
more

OrganiGram (OGI)

(Real Time Quote from BATS)

$1.88 USD

1.88
30,834

+0.02 (1.08%)

Updated Apr 29, 2024 09:54 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (142 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

Can Product Innovation Aid OrganiGram (OGI) in Q2 Earnings?

OrganiGram (OGI) is expected to have benefited from its focus on building brand equity and ongoing product innovation in the fiscal second quarter.

Implied Volatility Surging for Organigram (OGI) Stock Options

Investors need to pay close attention to Organigram Holdings (OGI) stock based on the movements in the options market lately.

Options Traders Expect Huge Moves in OrganiGram (OGI) Stock

Investors need to pay close attention to OrganiGram (OGI) stock based on the movements in the options market lately.

Can Focus on High-Growth Area Up OrganiGram (OGI) Q1 Earnings?

OrganiGram (OGI) is expected to have benefited from its firm focus on building brand equity and ongoing product innovation in the fiscal first quarter.

Can Focus on High-Growth Area Up OrganiGram (OGI) Q1 Earnings?

OrganiGram (OGI) is expected to have benefited from its firm focus on building brand equity and ongoing product innovation in the fiscal first quarter.

Why Earnings Season Could Be Great for OrganiGram (OGI)

OrganiGram (OGI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Implied Volatility Surging for OrganiGram (OGI) Stock Options

Investors need to pay close attention to OrganiGram (OGI) stock based on the movements in the options market lately.

What's in the Cards for OrganiGram (OGI) in Q4 Earnings?

According to OrganiGram (OGI), there is hugely unmet consumer demand for CBD products.

Tirthankar Chakraborty headshot

Marijuana Stocks to Buy or Avoid in November

We highlight three marijuana stocks that look like solid bargains, while one in particular should be avoided in the near future.

LabCorp (LH) Q3 Earnings Surpass Estimates, Tapers View

LabCorp (LH) impresses investors with third-quarter 2019 results on the robust performance of the Covance Drug Development segment.

Organigram (OGI) Catches Eye: Stock Jumps 8.6%

Organigram (OGI) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Options Traders Expect Huge Moves in OrganiGram (OGI) Stock

Investors need to pay close attention to OrganiGram (OGI) stock based on the movements in the options market lately.

Neena Mishra headshot

Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF

CNBC's cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.

Neena Mishra headshot

Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF

CNBC's cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.